跳至主要内容
临床试验/ACTRN12616000111471
ACTRN12616000111471已完成未知

A Pilot, Randomised, Unblinded, Feasibility, Safety and Biochemical and Physiological Efficacy Study of Targeted Mild Therapeutic Hypercapnia in Patients Undergoing Cardiopulmonary Bypass

Austin Health0 个研究点目标入组 31 人开始时间: 2016年2月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Austin Health
入组人数
31

研究概览

简要总结

Trend towards benefit of targeted mild therapeutic hypercapnia (slightly higher than normal targeting of blood carbon dioxide level) on cerebral oxygenation during cardiopulmonary bypass; non-inferior safety outcomes of intervention; finding of ongoing cerebral oxygen desaturation post-operatively across both intervention & control groups.

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Admitted to the Austin Hospital for elective cardiac surgery
  • 2. Aged 18 years or older
  • 3. Able to speak and read English

排除标准

  • 1. Pre-operative Mini-Mental State Examination score < 24
  • 2. Emergency cases
  • 3. History of neuropsychiatric disorders
  • 4. Contraindications to increased CO2 levels, such as right-sided heart failure, pulmonary hypertension, metabolic acidosis
  • 5. Aortic arch surgery

研究者

发起方
Austin Health

相似试验